These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33376514)

  • 1. Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress.
    Zhu Z; Ling X; Zhou H; Zhang C
    Exp Ther Med; 2021 Feb; 21(2):132. PubMed ID: 33376514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine Attenuates Cellular Injury and Apoptosis in H9c2 Cardiomyocytes by Regulating p-38MAPK and Endoplasmic Reticulum Stress.
    Zhu Z; Ling X; Zhou H; Zhang C; Yan W
    Drug Des Devel Ther; 2020; 14():4231-4243. PubMed ID: 33116411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
    Zhang Y; Zhao Q; Li X; Ji F
    Mol Cell Biochem; 2021 Jul; 476(7):2803-2812. PubMed ID: 33725228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
    Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
    Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway.
    Shi X; Liu Z; Li J
    Mol Med Rep; 2020 Oct; 22(4):3307-3315. PubMed ID: 32945482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of lycopene on hypoxia/reoxygenation-induced endoplasmic reticulum stress in H9C2 cardiomyocytes.
    Gao Y; Jia P; Shu W; Jia D
    Eur J Pharmacol; 2016 Mar; 774():71-9. PubMed ID: 26845695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury.
    Yuan T; Yang Z; Xian S; Chen Y; Wang L; Chen W; Long W; Che Y
    Exp Ther Med; 2020 Aug; 20(2):917-925. PubMed ID: 32742334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
    Yuan M; Meng XW; Ma J; Liu H; Song SY; Chen QC; Liu HY; Zhang J; Song N; Ji FH; Peng K
    Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
    Cai S; Liu Y; Cheng Y; Yuan J; Fang J
    J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
    Li J; Zhao Y; Zhou N; Li L; Li K
    J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine Attenuates Ischemia/Reperfusion-Induced Myocardial Inflammation and Apoptosis Through Inhibiting Endoplasmic Reticulum Stress Signaling.
    Yang YF; Wang H; Song N; Jiang YH; Zhang J; Meng XW; Feng XM; Liu H; Peng K; Ji FH
    J Inflamm Res; 2021; 14():1217-1233. PubMed ID: 33833544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
    Yang FY; Zhang L; Zheng Y; Dong H
    Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of dexmedetomidine on apoptosis and CHOP in hypoxia/reoxygenation injury A549 cell].
    Luo ZY; Gao H; Xiang BQ; Qiu XX; Dai YY; Wang WT
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):137-142. PubMed ID: 29926678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine protects H9C2 rat cardiomyocytes against hypoxia/reoxygenation injury by regulating the long non-coding RNA colon cancer-associated transcript 1/microRNA-8063/Wnt/β-catenin axis.
    Liu C; Xu R
    Bioengineered; 2022 May; 13(5):13300-13311. PubMed ID: 35635079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHLDA3 inhibition attenuates endoplasmic reticulum stress-induced apoptosis in myocardial hypoxia/reoxygenation injury by activating the PI3K/AKT signaling pathway.
    Liu K; Chen Y; Ai F; Li YQ; Zhang K; Zhang WT
    Exp Ther Med; 2021 Jun; 21(6):613. PubMed ID: 33936270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 attenuates endoplasmic reticulum stress-induced apoptosis in H9c2 cardiomyocytes during hypoxia/reoxygenation through the GLP-1R/PI3K/Akt pathways.
    Guan G; Zhang J; Liu S; Huang W; Gong Y; Gu X
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):715-722. PubMed ID: 30762075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine inhibits endoplasmic reticulum stress to suppress pyroptosis of hypoxia/reoxygenation-induced intestinal epithelial cells via activating the SIRT1 expression.
    Liu X; Leng Y; Lv X; Lv J; Zhang M; Shi Y
    J Bioenerg Biomembr; 2021 Dec; 53(6):655-664. PubMed ID: 34586578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide attenuates endoplasmic reticulum stress in H9c2 cardiomyocytes underwent hypoxia/reoxygenation injury under high glucose/high fat conditions.
    Chang P; Zhang M; Zhang X; Li G; Hu H; Wu J; Wang X; Yang Z; Zhang J; Chen W; Ren M; Li X; Zhu M; Chen B; Yu J
    Peptides; 2019 Jan; 111():103-111. PubMed ID: 29689346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine Protects Human Renal Tubular Epithelial HK-2 Cells against Hypoxia/Reoxygenation Injury by Inactivating Endoplasmic Reticulum Stress Pathway.
    Zhai M; Han M; Huang X; Kang F; Yang CH; Li J
    Cell J; 2021 Sep; 23(4):457-464. PubMed ID: 34455722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
    Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
    J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.